Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, adult, aggressive, ancillary, aspect, atezolizumab, Benchmark, bifunctional, buyer, cGLP, chance, cis, Cmax, CMO, cutoff, DIPN, divisional, draining, dynamic, EF, endometrial, equilibrium, excise, geomean, geometric, Hutton, inset, inventory, Japanese, kDa, kidney, Ladenburg, lieu, ligand, lt, Marburg, McNeil, MCSA, Meso, mono, monotherapy, MSD, native, ovarian, pattern, peaked, POC, polyhistidine, pre, PROC, radiolabeled, radiolabeling, randomized, reclassified, refund, refunded, regression, reissued, Rick, Roche, RSA, Russian, scan, SOC, stable, tag, Taxation, Tecentriq, tertiary, Thalmann, tightening, TME, UK, Virocell
Removed:
Abdominal, AEs, Aid, alkaline, Alopecia, Anemia, Anorexia, anti, Apexian, Appetite, Arthralgia, Asthenia, Bilirubin, biomarker, bispecific, Cameron, cancelable, Constipation, Cough, Dehydration, Diarrhea, Dyspnoea, edema, effector, elicited, EPSP, erythema, Fatigue, Fibrinogen, forthcoming, furniture, Hakkoum, Headache, helper, Hematuria, Insomnia, Lethargy, loan, Malaise, mg, Mucosal, Nausea, Neutropenia, Paycheck, phosphatase, Platelet, PPP, Pyrexia, quantify, ranged, streptozotocin, twofold, unsecured, Vomiting, wild, WT
Filing tables
Filing exhibits
SONN similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-238542, 333-256183, 333-264832 and 333-274122) on Form S-8, (Nos. 333-235301, 333-237795, 333-237354, 333-251406, 333-252049 and 333-267171) on Form S-3, and (Nos. 333-258092, 333-269307, 333-273516 and 333-274581) on Form S-1 of our report dated December 14, 2023, with respect to the consolidated financial statements of Sonnet BioTherapeutics Holdings, Inc.
/s/ KPMG LLP
Philadelphia, Pennsylvania
December 14, 2023